Education
About Us
Working with TipRanks
Follow Us
Pluri Inc. (PLUR)
:PLUR
PLUR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.33 - $7.13
Previous CloseN/A
Volume1.48K
Average Volume (3M)13.08K
Market Cap
$39.28M
Enterprise Value$43.10M
Total Cash (Recent Filing)$26.27M
Total Debt (Recent Filing)$31.19M
Price to Earnings (P/E)―
Beta1.08
Next Earnings
Feb 11, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.68
Shares Outstanding7,832,601
10 Day Avg. Volume5,809
30 Day Avg. Volume13,077
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.10
Enterprise Value/Revenue41.68
Enterprise Value/Gross Profit90.17
Enterprise Value/Ebitda-2.18
Forecast
1Y Price Target
$12.00Price Target Upside132.56% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Pluri News
PLUR FAQ
What was Pluri Inc.’s price range in the past 12 months?
Pluri Inc. lowest stock price was $3.33 and its highest was $7.13 in the past 12 months.
What is Pluri Inc.’s market cap?
Pluri Inc.’s market cap is $39.28M.
When is Pluri Inc.’s upcoming earnings report date?
Pluri Inc.’s upcoming earnings report date is Feb 11, 2025 which is 178 days ago.
How were Pluri Inc.’s earnings last quarter?
Currently, no data Available
Is Pluri Inc. overvalued?
According to Wall Street analysts Pluri Inc.’s price is currently Undervalued.
Does Pluri Inc. pay dividends?
Pluri Inc. does not currently pay dividends.
What is Pluri Inc.’s EPS estimate?
Pluri Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pluri Inc. have?
Pluri Inc. has 7,832,601 shares outstanding.
What happened to Pluri Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Pluri Inc.?
Currently, no hedge funds are holding shares in PLUR
Pluri Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$12.00 (132.56% Upside)
$12.00 (132.56% Upside)
Blogger Sentiment
Bullish
PLUR Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $2.4M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-13.44%
12-Months-Change
Fundamentals
Return on Equity
-1205.58%
Trailing 12-Months
Asset Growth
2.79%
Trailing 12-Months
Company Description
Pluri Inc.
Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trials for the muscle recovery after surgery for hip fracture; in Phase II clinical trails for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18 for incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as a solution for the treatment of acute radiation syndrome. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.
Pluri (PLUR) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
PLUR Stock 12 Month Forecast
Average Price Target
$12.00
▲(132.56% Upside)
Technical Analysis
Tempest Therapeutics
―
Daré Bioscience
―
Clene
―
Neurosense Therapeutics Ltd.
―
CytoMed Therapeutics Limited
―
Ownership Overview
28.28% Insiders
0.04% Mutual Funds
0.15% Other Institutional Investors
71.18% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---